Novartis BioMedical Research (BR) is the innovation engine of Novartis, collaborating across the company and beyond to focus on new technologies with the potential to produce therapeutic breakthroughs for patients. Translational Medicine (TM) is the clinical research arm of Novartis BR, playing a pivotal role in bringing innovative medicines to patients by bridging drug discovery and clinical application. The TM Discovery & Profiling (TMDP) group drives innovative science from discovery to the patient through the selection, profiling, and development of medicines. As a Cardiovascular Metabolism (CVM) TM Expert, you will collaborate with the CVM TM Head or other experienced TM Experts to develop high value decision-strategies for the Translational Medicine component of drug development projects and to lead global cross-functional project teams through the PoC phase and beyond.
Dieses Unternehmensprofil wurde automatisch erstellt. Wenn du für Novartis Schweiz arbeitest, kannst du das Profil jetzt beanspruchen und verifizieren – kostenlos und in wenigen Minuten.
Translational Medicine includes about 900 associates globally and is comprised of physicians and clinical researchers who collaborate in global cross-functional project teams, working closely with colleagues in biology and chemistry to identify targets and develop new therapies.